fda spravato - Search News

FDA approves Spravato

Yahoo · 20h

FDA approves Spravato as first stand-along nasal spray to treat drug-resistant depression

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

Popular Science · 1d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

UPI News on MSN · 1d

FDA approves Spravato, first monotherapy nasal spray to treat depression

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

IFLScience3h

FDA Approves First-Ever Standalone Therapy For Treatment-Resistant Depression

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...

devdiscourse1d

Global Health Watch: Key Updates and Challenges

This summary covers the latest health-related news, including FDA's approval of Spravato as a standalone depression treatment ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA approves Spravato

Trending now

Related topics